- Home
- ELTK vs ATNM Comparison
ELTK vs ATNM Comparison
Compare ELTK & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTK
- ATNM
- Stock Information
- Founded
- ELTK 1970
- ATNM 2000
- Country
- ELTK Israel
- ATNM United States
- Employees
- ELTK N/A
- ATNM N/A
- Industry
- ELTK Electrical Products
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- ELTK Technology
- ATNM Health Care
- Exchange
- ELTK Nasdaq
- ATNM Nasdaq
- Market Cap
- ELTK 57.5M
- ATNM 46.5M
- IPO Year
- ELTK 1997
- ATNM N/A
- Fundamental
- Price
- ELTK $8.53
- ATNM $1.21
- Analyst Decision
- ELTK
- ATNM Strong Buy
- Analyst Count
- ELTK 0
- ATNM 4
- Target Price
- ELTK N/A
- ATNM $8.75
- AVG Volume (30 Days)
- ELTK 8.1K
- ATNM 1.4M
- Earning Date
- ELTK 05-20-2025
- ATNM 04-29-2025
- Dividend Yield
- ELTK 2.23%
- ATNM N/A
- EPS Growth
- ELTK N/A
- ATNM N/A
- EPS
- ELTK 0.63
- ATNM N/A
- Revenue
- ELTK $46,527,000.00
- ATNM N/A
- Revenue This Year
- ELTK $18.60
- ATNM N/A
- Revenue Next Year
- ELTK $9.04
- ATNM N/A
- P/E Ratio
- ELTK $13.54
- ATNM N/A
- Revenue Growth
- ELTK N/A
- ATNM N/A
- 52 Week Low
- ELTK $7.65
- ATNM $1.03
- 52 Week High
- ELTK $12.47
- ATNM $10.24
- Technical
- Relative Strength Index (RSI)
- ELTK 45.32
- ATNM 43.76
- Support Level
- ELTK $8.39
- ATNM $1.18
- Resistance Level
- ELTK $8.71
- ATNM $1.34
- Average True Range (ATR)
- ELTK 0.32
- ATNM 0.15
- MACD
- ELTK 0.14
- ATNM -0.03
- Stochastic Oscillator
- ELTK 83.02
- ATNM 11.99
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnects. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.